Riskpilot← Back to searchSign inGet full accessCLOH Medical AB
ABActiveOrg 5567996060Danderydsvägen 130General medical practice activities · NACE 8621Est. 20101 employees
Revenue 2025
SEK 0
EBITDA margin
—
+23% vs 2024
Equity ratio
73.4%
Financial strength
Net profit 2025
SEK 50K
-20% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -36K | +23% |
| Net profit | SEK 50K | -20% |
| Total assets | SEK 1,4M | -9% |
| Equity | SEK 1M | -13% |
| Employees | 1 | — |
Legal name
CLOH Medical AB
Org number
5567996060
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
20 januari 2010
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget ska bedriva läkarvård och utbildning samt konsultverksamhet inom detsamma, äga och förvalta fast och lös egendom och värdepapper samt därmed förenlig verksamhet.
Address
Danderydsvägen 130
Email
lyckeborg.heimburger@bredband.net
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | −0 | −0 | −0 | −0 |
| EBITDA | −32 | −61 | −61 | −47 | −36 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −32 | −61 | −61 | −47 | −36 |
| Net financials | 81 | 82 | 88 | 128 | 129 |
| Profit before tax | 112 | 21 | 27 | 82 | 67 |
| Tax | −27 | −9 | −9 | −20 | −17 |
| Net profit | 85 | 12 | 18 | 62 | 50 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 987 | 1 848 | 1 688 | 1 545 | 1 413 |
| Equity | 1 691 | 1 516 | 1 338 | 1 196 | 1 037 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 211 | 247 | 265 | 265 | 265 |
| Total debt | 211 | 247 | 265 | 265 | 265 |
EBITDA margin
-3577500.0%
This company
15.8%
Market median
-22642505% vs market
20212025
Equity ratio
73.4%
This company
38.2%
Market median
+92% vs market
20212025
Return on equity
4.8%
This company
18.4%
Market median
-74% vs market
20212025
Net profit margin
5025400.0%
This company
8.1%
Market median
+62041875% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.36×
This company
0.62×
Market median
+42% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EC Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CLOH Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Evy Catharina Lyckeborg Heimbürger | Chief Executive Officer | 0 companies |
| Olof Peter Erik Heimbürger | Deputy Board Member | 0 companies |